HSP90AA1 and cancer: Moreover, malignant transformation is associatedwith proteotoxic and nutritional stress, which increases Hsp90 levels.20 Inhibition of Hsp90 simultaneously affects multipleoncogenic proteins and cancer pathways, making Hsp90 an attractivetarget for anticancer drug development, including TNBC.21